Im Jahr 2006 und 2007 wurde die Radsportwelt von unzähligen Dopingfällen erschüttert, die vor allem durch das Beschuldigen mehrerer Top-Fahrer, wie Jan Ulrich, Ivan Basso oder Floyd Landis, flächendeckendes Ausmaß annahm. Die damit verbunden notwendige Analyse des Dopings im Radsport und im speziellen der Tour de France, befasst sich mit den gegebenen Dopingmethoden, wie EPO- und Blutdoping blickt aber auch auf neuartige Dopingmethoden und möglicher Aufdeckungsmethoden. Zudem beschreibe ich in meiner Arbeit auch die biochemischen Vorgänge des Doping, deren Effekt und Folgen.
Table of Contents
1 Introduction
2 The use of performance enhancing substances
2.1 EPO-Doping
2.2 Blood-doping
2.3 Types of blood-doping
2.4 Performance enhancing tests
2.5 Health risks of doping
3. Detection of doping
4. Testosterone doping
5. New doping methods in professional sport
5.1 Detection of gene doping and health risks
6 Doping and detection – Policies of the WADA and professional cycling organizations
Research Objectives and Key Topics
This paper examines the evolution and impact of performance-enhancing drugs in professional cycling, specifically focusing on the Tour de France. The research aims to evaluate how different doping substances function, their physiological effects on athletes, and the effectiveness of modern anti-doping detection methods within the framework of WADA policies and organizational challenges.
- Physiological mechanisms of EPO and testosterone doping.
- Methods and challenges in detecting autologous and homologous blood doping.
- Analysis of specific doping cases, including Alexander Vinokourov and Michael Rasmussen.
- Emerging threats such as gene doping in elite sports.
- The role and limitations of WADA and UCI anti-doping regulations.
Excerpt from the Book
2.1 EPO-Doping
Due to the improvement of the illegal doping industry there are several possibilities to use performance enhancing drugs in professional sports.
General speaking it is a huge problem for anti-doping organizations and the science to fight doping in advanced. Especially in cycling the use of EPO-doping was common over decades and its detection experienced success just over the past few years.
Erythropoietin, EPO, is a protein hormone produced by the body. The production process starts in the kidney. From the kidney EPO will be transported to the bone marrow via blood vessels. In the red bone marrow the production of red and white blood cells takes place. The bone marrow fills gaps in the bones with red blood cells and platelets. Statistically the bone marrow contains about 10% of the blood inside the body. The size of a red blood cell is about 6-8 micrometres and the platelets range from 2-4 micrometres.
The red blood cells are decisive for the performance in endurance sports because the red blood cells transport the oxygen inside the body. The reason for the oxygen transport is the haemoglobin which is part of the red blood cells.
Summary of Chapters
1 Introduction: Provides an overview of how endurance sports have been impacted by the professional doping market and outlines the investigative focus on cycling.
2 The use of performance enhancing substances: Explores the primary reasons for doping and details the biological functions of EPO, blood-doping, and testosterone.
2.1 EPO-Doping: Explains the natural production of EPO and how its artificial manipulation enhances oxygen transport for improved athletic performance.
2.2 Blood-doping: Details the history and methods of using blood transfusions to boost haemoglobin levels, particularly in the context of mountain stages.
2.3 Types of blood-doping: Distinguishes between autologous transfusions (using one's own blood) and homologous transfusions (using donor blood).
2.4 Performance enhancing tests: Discusses scientific findings regarding the tangible improvements in oxygen intake and performance times resulting from blood doping.
2.5 Health risks of doping: Outlines the severe medical consequences of doping, including thrombosis, blood clotting, and potential heart failure.
3. Detection of doping: Reviews the evolution of detection methods, such as the antigen-method used to identify foreign blood in athletes.
4. Testosterone doping: Examines the anabolic effects of testosterone and the procedures used to detect prohibited levels via the testosterone/epitestosterone ratio.
5. New doping methods in professional sport: Investigates the future of performance enhancement through gene doping and its potential impact on competitive sports.
5.1 Detection of gene doping and health risks: Addresses the significant challenges in identifying genetic manipulation and the unknown long-term health hazards associated with it.
6 Doping and detection – Policies of the WADA and professional cycling organizations: Analyzes the global anti-doping strategy, the role of WADA and UCI, and the conflicts between these bodies and professional teams.
Keywords
Doping, EPO, Blood-doping, Testosterone, Professional Cycling, Tour de France, WADA, UCI, Gene doping, Hematocrit level, Anti-doping detection, Performance enhancement, Erythropoietin, Blood transfusion, Athlete’s passport
Frequently Asked Questions
What is the core subject of this research paper?
The paper focuses on the prevalence and evolution of doping practices in professional cycling, analyzing how various performance-enhancing substances affect athletes and how anti-doping organizations attempt to detect these cheats.
What are the central thematic fields covered?
The research covers physiological impacts of doping, the specific categories of drugs like EPO and testosterone, detection technology, the dangers to athlete health, and the organizational policies of the WADA and UCI.
What is the primary goal of this study?
The goal is to investigate how endurance sports like cycling are influenced by doping, to understand the physiological benefits athletes seek, and to assess the success of current detection measures during events like the Tour de France.
Which scientific methods are analyzed regarding detection?
The text discusses hematocrit level monitoring, the antigen-method for identifying blood transfusions, urine sample analysis for hormone ratios, and the prospective implementation of the Athlete's passport.
What does the main body of the work cover?
The main body details specific doping techniques, including EPO and blood-doping, explores testosterone usage, identifies health risks like heart attacks and blood clots, and investigates emerging techniques such as gene doping.
How would you characterize this paper through its keywords?
Key terms include Doping, EPO, Blood-doping, Testosterone, Professional Cycling, WADA, and Gene doping, which collectively reflect a focus on the intersection of physiology, pharmacology, and sports management.
What role does the Tour de France play in this investigation?
The Tour de France serves as the primary case study, demonstrating the failure of historical anti-doping systems and highlighting the pressure on riders to perform in difficult mountain stages.
How does the author view the future of anti-doping?
The author suggests that while organizations like WADA and UCI have increased their efforts and investment in science, the doping industry remains a significant challenge that requires a fundamental change in the attitudes of the riders themselves.
- Quote paper
- Daniel Barthold (Author), 2008, Doping and Detection in Professional Sport, Munich, GRIN Verlag, https://www.grin.com/document/135534
